Network
Beneficiaries
Asscociated Partners

Sebastian Kobold
Coordinator Professor and Deputy Director of the Division of Clinical Pharmacology Ludwig-Maximilians-Universität Division of Clinical Pharmacology
Lindwurmstraße 2a
D- 80337 München
Germany
+49 (0) 89 440057325

Michael von Bergwelt
Director Department of Medicine III, University Hospital, LMU Munich Spokesperson German Cancer Consortium Munich-LMU Ludwig-Maximilians-Universität Medizinische Klinik und Poliklinik III Klinikum der Universität München
Marchioninistraße 15
D-81377 Munich
Germany
+49 (0) 89 440075551

Sebastian Theurich
Professor for Cancer- and Immunometabolism, Attending Physician, Lead of Myeoma Program Ludwig-Maximilians-Universität Gene Center Munich
Feodor-Lynen-Straße 25 and Department of Medicine III, LMU University Hospital
D-81377 Munich
Germany
+49 (0) 89 2180 76878

Sine Reker Hadrup
Professor Danmarks Tekniske Universitet Department of Health Technology Kemitorvet
Building 204, room 154
2800 Kgs. Lyngby
Denmark
+45 (0) 35 886290

Tanja D. de Gruijl
Professor Translational Tumor Immunology and Head of the Immunotherapy Laboratory and the Tumor Immunomonitoring Unit Amsterdam University Medical Centers Dept. Medical Oncology Amsterdam UMC
VUmc, CCA 2.44 DE BOELELAAN 1117
1081 HV Amsterdam Post
Netherlands
+31 (0) 20 4444063

Lionel Apetoh
Associate Professor of Immunology at INSERM Institut National de la Santé et de la Recherche Médicale INSERM U1100
10 boulevard Tonnellé
37000
Tours France
+33 (0)3 80393371

Christian Buchholz
Head of Molecular Biotechnology and Gene Therapy Paul-Ehrlich-Institut
Paul-Ehrlich-Str. 51-59
63225
Langen Germany
0049 6103 77 0

Jessica Hartmann
Senior Research Associate and Regulatory Assessor Paul-Ehrlich-Institut Division of Medical Biotechnology
Paul-Ehrlich-Str. 51-59
D-63225 Langen
Germany
+49 (0) 6103774026

Per Thor Straten
Director of Center for Cancer Immunotherapy Region Hovedstaden, University Hospital Herlev Center for Cancer Immunotherapy
Herlev Ringvej 75
DK-2730 Herlev
Denmark
+45 (0) 38 68 93 39

Alfred Zippelius
Head Cancer Immunology Universität Basel Department of Biomedicine (DBM)
Hebelstrasse 20
CH-4031Basel
Switzerland
+41 (0)61 265 50 74

Heinz Läubli
Research Group Leader of Cancer Immunotherapy Universität Basel Department of Biomedicine (DBM)
Hebelstrasse 20
CH-4031Basel
Switzerland
+41 (0)61 265 23 55

Christian Klein
Department Head Cancer Immunotherapy Discovery 3 & Site Head Roche Innovation Center Zurich, Roche Pharma Research & Early Development Roche Glycart AG, Roche Innovation Center Zurich
Wagistrasse 10
CH-8952 Schlieren
Switzerland
+41 (0) 43 215 1628

Robert Hawkins
Chief Strategy Advisor Instil Bio Inc
48 Grafton Street
Manchester M13 9XX
UK
+44 7720708245

Laurence Zitvogel
Professor of Immunology at UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay
114, rue Édouard-Vaillant
F- 94805 Villejuif-Cedex
France
+33 (0)1 42 11 42 11

Jörg Mittelstät
Group Leader - R&D Reagents CAR technology research and translation - Miltenyi Biotec B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach
Germany
+49 (0) 02204 8306-0

Sonja Schallenberg
Team Coordinator clinical T cell processing development R&D Immunotherapy - Miltenyi Biotec B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429
Bergisch Gladbach Germany
02204 8306-0

Michal Lotem
Head of Center for Melanoma and Cancer Immunotherapy Sharett Institute Hadassah Medical Organization, HMO
POB12 000 Jerusalem
Israel
+972-2-677-6781

Graham Ball
CSO Intelligent OMICS Ltd
C BioCity 1 Pennyfoot Street
Nottingham NG1 1GF
UK
+44 (0)115 848 8308

David Andreu Sanz
ESR1, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich
Lindwurmstr. 2
80337
Munich Germany

Keerthana Ramanathan
ESR2, Reker's Lab, Danmarks Tekniske Universitet Department of Health Technology Kemitorvet
Building 204, room 154
2800 Kgs. Lyngby
Denmark

Fabian Richter
ESR4, Apetoh's Lab, Institut National de la Santé et de la Recherche Médicale INSERM U1100
10 boulevard Tonnellé
37000
Tours France

Johanna Nimmerfroh
ESR 7, Zippelius and Läubli's Lab, Cancer Immunology, Cancer Immunotherapy, Department of Biomedicine (DBM), Universität Basel
Hebelstrasse 20
4031
Basel Switzerland

Emanuele Carlini
ESR 8, Kobold's Lab, Division of Clinical Pharmacology, Ludwig-Maximilians-Universität Munich
Lindwurmstr. 2
80337
Munich Germany

Laura Marcos Kovandzic
ESR 11, Zitvogel's Lab, UMR 1015 Immunologie des tumeurs immunothérapie contre le cancer Université Paris-Saclay
114, rue Édouard-Vaillant
94805
Villejuif-Cedex Paris France

Adriano Carboniero
ESR 12, Theurich's Lab, Gene Center Munich, Ludwig-Maximilians-Universität Munich
Feodor-Lynen-Straße 25 and Department of Medicine III, LMU University Hospital
81377
Munich Germany

Valeria Durante
ESR 13, Mittelstätt and Schallenberg's Group, R&D Reagents CAR technology research and translation, Team clinical T cell processing development Miltenyi Biotec B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429
Bergisch Gladbach Germany
- 12 beneficiaries
- 5 associated partners
- 12 academic partners
- 4 industrial partners
- 1 public authority
- 7 countries